163 related articles for article (PubMed ID: 29364521)
1. Biosafety in Handling Gene Transfer Vectors.
Swindle S
Curr Protoc Hum Genet; 2018 Jan; 96():12.1.1-12.1.17. PubMed ID: 29364521
[TBL] [Abstract][Full Text] [Related]
2. Biosafety in handling gene transfer vectors.
Braun A
Curr Protoc Hum Genet; 2006 Aug; Chapter 12():Unit 12.1. PubMed ID: 18428388
[TBL] [Abstract][Full Text] [Related]
3. Biosafety considerations using gamma-retroviral vectors in gene therapy.
Deichmann A; Schmidt M
Curr Gene Ther; 2013 Dec; 13(6):469-77. PubMed ID: 24195605
[TBL] [Abstract][Full Text] [Related]
4. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy.
Vigna E; Naldini L
J Gene Med; 2000; 2(5):308-16. PubMed ID: 11045424
[TBL] [Abstract][Full Text] [Related]
5. Biosafety of recombinant adeno-associated virus vectors.
Dismuke DJ; Tenenbaum L; Samulski RJ
Curr Gene Ther; 2013 Dec; 13(6):434-52. PubMed ID: 24195602
[TBL] [Abstract][Full Text] [Related]
6. Production and titration of lentiviral vectors.
Barde I; Salmon P; Trono D
Curr Protoc Neurosci; 2010 Oct; Chapter 4():Unit 4.21. PubMed ID: 20938923
[TBL] [Abstract][Full Text] [Related]
7. Viral-mediated gene therapy and genetically modified therapeutics: A primer on biosafety handling for the health-system pharmacist.
Blind JE; McLeod EN; Campbell KJ
Am J Health Syst Pharm; 2019 May; 76(11):795-802. PubMed ID: 31361814
[TBL] [Abstract][Full Text] [Related]
8. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
Neschadim A; McCart JA; Keating A; Medin JA
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
[TBL] [Abstract][Full Text] [Related]
9. Biosafety issues in lentivector production.
Delenda C; Audit M; Danos O
Curr Top Microbiol Immunol; 2002; 261():123-41. PubMed ID: 11892244
[No Abstract] [Full Text] [Related]
10. Biosafety challenges for use of lentiviral vectors in gene therapy.
Rothe M; Modlich U; Schambach A
Curr Gene Ther; 2013 Dec; 13(6):453-68. PubMed ID: 24195603
[TBL] [Abstract][Full Text] [Related]
11. Antigen-presenting cell-targeted lentiviral vectors do not support the development of productive T-cell effector responses: implications for in vivo targeted vaccine delivery.
Goyvaerts C; De Vlaeminck Y; Escors D; Lienenklaus S; Keyaerts M; Raes G; Breckpot K
Gene Ther; 2017 Jun; 24(6):370-375. PubMed ID: 28540936
[TBL] [Abstract][Full Text] [Related]
12. Biosafety of lentiviral vectors.
Debyser Z
Curr Gene Ther; 2003 Dec; 3(6):517-25. PubMed ID: 14683448
[TBL] [Abstract][Full Text] [Related]
13. Lentiviral vectors: turning a deadly foe into a therapeutic agent.
Trono D
Gene Ther; 2000 Jan; 7(1):20-3. PubMed ID: 10680011
[TBL] [Abstract][Full Text] [Related]
14. State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations.
Pauwels K; Gijsbers R; Toelen J; Schambach A; Willard-Gallo K; Verheust C; Debyser Z; Herman P
Curr Gene Ther; 2009 Dec; 9(6):459-74. PubMed ID: 20021330
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
Sinn PL; Sauter SL; McCray PB
Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy of the central nervous system: general considerations on viral vectors for gene transfer into the brain.
Serguera C; Bemelmans AP
Rev Neurol (Paris); 2014 Dec; 170(12):727-38. PubMed ID: 25459120
[TBL] [Abstract][Full Text] [Related]
17. Biosafety assessment of human mesenchymal stem cells engineered by hybrid baculovirus vectors.
Chen CY; Wu HH; Chen CP; Chern SR; Hwang SM; Huang SF; Lo WH; Chen GY; Hu YC
Mol Pharm; 2011 Oct; 8(5):1505-14. PubMed ID: 21197956
[TBL] [Abstract][Full Text] [Related]
18. Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model.
Björklund A; Kirik D; Rosenblad C; Georgievska B; Lundberg C; Mandel RJ
Brain Res; 2000 Dec; 886(1-2):82-98. PubMed ID: 11119690
[TBL] [Abstract][Full Text] [Related]
19. Production and titration of lentiviral vectors.
Salmon P; Trono D
Curr Protoc Hum Genet; 2007 Jul; Chapter 12():Unit 12.10. PubMed ID: 18428406
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral vectors: their molecular design, safety, and use in laboratory and preclinical research.
Dropulić B
Hum Gene Ther; 2011 Jun; 22(6):649-57. PubMed ID: 21486177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
